Forss A, Clements M, Myrelid P, Strid H, et al. Prospective observational study on Stelara (ustekinumab) assessing effectiveness in Crohn's disease (PROSE): a 16-week follow-up. Scand J Gastroenterol 2021;56:680-686.
PMID: 33794731